» Articles » PMID: 19075563

Cell Cycle Control by the CDC25 Phosphatases

Overview
Specialties Chemistry
Oncology
Date 2008 Dec 17
PMID 19075563
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Cell division cycle 25 (CDC25) phosphatases are key actors in eukaryotic cell cycle control. They are responsible for the dephosphorylations that activate the cyclin-dependent kinases (CDK) at specific stages of the cell cycle. Human CDC25A, CDC25B and CDC25C are also central targets and regulators of the G2/M checkpoint mechanisms activated in response to DNA injury. The expression and activity of these enzymes is finely regulated by multiple mechanisms including post-translational modifications, interactions with regulatory partners, control of their intracellular localization, and cell cycle-regulated degradation. Altered expression of these phosphatases is associated with checkpoint bypass and genetic instability. Accordingly, increased expression of CDC25A and CDC25B is found in many high-grade tumors and is correlated with poor prognosis in human cancers. This review summarizes our current knowledge within this domain and discusses the data that support therapeutic strategies targeting CDC25 activity in the treatment of cancer.

Citing Articles

RNA modifications in gynecological cancer: current status and future directions.

He W, Hong X, Chen G, Luo X, Lin Y Front Med (Lausanne). 2024; 11:1314075.

PMID: 38343637 PMC: 10853395. DOI: 10.3389/fmed.2024.1314075.


Sulforaphane-Induced Cell Mitotic Delay and Inhibited Cell Proliferation via Regulating CDK5R1 Upregulation in Breast Cancer Cell Lines.

Hung C, Tsai T, Lee K, Hsu Y Biomedicines. 2023; 11(4).

PMID: 37189614 PMC: 10135833. DOI: 10.3390/biomedicines11040996.


Radiotherapy and radio-sensitization in H3 -mutated diffuse midline gliomas.

Liu C, Kuang S, Wu L, Cheng Q, Gong X, Wu J CNS Neurosci Ther. 2023; 29(7):1721-1737.

PMID: 37157237 PMC: 10324372. DOI: 10.1111/cns.14225.


Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the Horizon.

Luserna di Rora A, Jandoubi M, Martinelli G, Simonetti G Molecules. 2023; 28(3).

PMID: 36770891 PMC: 9920029. DOI: 10.3390/molecules28031224.


Cyclin A-CDK1 suppresses the expression of the CDK1 activator CDC25A to safeguard timely mitotic entry.

Ng L, Ma H, Poon R J Biol Chem. 2023; 299(3):102957.

PMID: 36717077 PMC: 9986519. DOI: 10.1016/j.jbc.2023.102957.